SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and... SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and readily available health and wellness items. Its primary strategic pillars include the laboratory synthesis of cannabinoids, advanced drug discovery, the formulation of dietary aids, and the creation of cosmetic solutions. Formerly operating as Ledgertech SE, the company is headquartered in Munich, Germany.
